Business
Jane Griffiths - External Directorship
Jane Griffiths - External Directorship.
About this update from Johnson Matthey Plc
[{"type":"text","content":"\n \n \n \n RNS Number : 8129Q\n Johnson Matthey PLC\n 01 November 2021\n \n \n \n \n \n \n \n 1st November 2021\n \n \n \n \n \n Johnson Matthey Plc\n \n \n (the Company)\n \n \n \n \n \n \n \n \n \n \n \n Jane Griffiths - External Directorship\n \n \n \n \n \n In accordance with Listing Rule 9.6.14R(2), the Company announces that Jane Griffiths, Non-Executive Director, is appointed as Non-Executive Chair of Redx Pharma Plc, a company listed on the Alternative Investment Market of the London Stock Exchange with effect from 1st December 2021.\n \n \n \n \n \n \n \n \n \n \n \n ENDS\n \n \n \n \n \n \n \n \n Johnson Matthey Plc is listed on the London Stock Exchange (JMAT)\n \n \n Registered in England & Wales number: 00033774\n \n \n Legal Entity Identifier number: 2138001AVBSD1HSC6Z10\n \n \n \n \n \n \n \n \n \n This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.\n END\n \n RDNGZMFGDMZGMZM\n ","length":3389,"tagName":"div"}]